InflaRx, a bm|t Investee-Partner, completed a minimum 75 Mio. USD equity raise, greatly enhancing the company’s ability to continue advancing its promising pipeline through multiple significant milestones.

InflaRx N.V. (Nas­daq: IFRX), a clin­i­­cal-stage bio­phar­ma­ceu­ti­cal com­pany devel­op­ing anti-inflam­­ma­­tory ther­a­peu­tics by tar­get­ing the com­ple­ment sys­tem, announced today that it has com­pleted its under­writ­ten public

read more »

Million investment for Influnate GmbH from Erfurt

Influ­nate GmbH offers a rev­o­lu­tion­ary tech­nol­ogy in the field of ’social media pay­ment’. With this it is pos­si­ble to make mon­e­tary trans­ac­tions directly within the com­ment sec­tion of a social media plat­form. This not only changes the pos­si­bil­i­ties of mon­e­ti­za­tion for artists and cre­atives, the way char­ity appeals are cre­ated or social com­merce trans­ac­tions are processed, but also fun­da­men­tally changes the value cre­ation on social networks.

read more »